Eric Segal

1.0k total citations
38 papers, 534 citations indexed

About

Eric Segal is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric Segal has authored 38 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 21 papers in Pediatrics, Perinatology and Child Health and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric Segal's work include Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (8 papers). Eric Segal is often cited by papers focused on Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (17 papers) and Neuroscience and Neuropharmacology Research (8 papers). Eric Segal collaborates with scholars based in United States, United Kingdom and Japan. Eric Segal's co-authors include Ian Miller, Jerzy P. Szaflarski, Michael Chez, Enrique Carrazana, Adrián L. Rabinowicz, Michael R. Sperling, Laurie E. Seltzer, Robert Flamini, Arie Weinstock and James W. Wheless and has published in prestigious journals such as Neurology, Critical Care Medicine and Epilepsia.

In The Last Decade

Eric Segal

35 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Segal United States	12	310	189	167	151	47	38	534
Antonella Riva Italy	13	217 0.7×	134 0.7×	57 0.3×	131 0.9×	36 0.8×	59	535
Baibing Chen United States	12	394 1.3×	308 1.6×	31 0.2×	178 1.2×	58 1.2×	21	598
Sarah Youssof United States	8	66 0.2×	78 0.4×	314 1.9×	112 0.7×	80 1.7×	14	560
Kim Dao Switzerland	10	64 0.2×	127 0.7×	325 1.9×	100 0.7×	62 1.3×	28	506
Kerstin Alexandra Klotz Germany	12	251 0.8×	109 0.6×	105 0.6×	144 1.0×	77 1.6×	41	367
J L Herranz Spain	14	542 1.7×	514 2.7×	23 0.1×	112 0.7×	33 0.7×	64	708
Martin Ebinger Germany	3	123 0.4×	100 0.5×	87 0.5×	39 0.3×	45 1.0×	4	386
Johannes A. Carpay Netherlands	15	647 2.1×	373 2.0×	26 0.2×	122 0.8×	105 2.2×	32	750
Dean Sarco United States	10	150 0.5×	240 1.3×	42 0.3×	60 0.4×	54 1.1×	16	633
Alexander Legge United States	9	406 1.3×	328 1.7×	30 0.2×	182 1.2×	72 1.5×	11	555

Countries citing papers authored by Eric Segal

Since Specialization

Citations

This map shows the geographic impact of Eric Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Segal more than expected).

Fields of papers citing papers by Eric Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Segal. The network helps show where Eric Segal may publish in the future.

Co-authorship network of co-authors of Eric Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Segal. A scholar is included among the top collaborators of Eric Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Segal. Eric Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segal, Eric, John M. Stern, Danielle A. Becker, et al.. (2025). Treatment of Status Epilepticus At and After T1 With Diazepam Nasal Spray: A Combined Cohort Analysis (P8-9.013). Neurology. 104(7_Supplement_1).

Wheless, James W., Robert Wechsler, Patricia Penovich, et al.. (2023). Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study. Epilepsy & Behavior. 147. 109369–109369. 5 indexed citations

Peters, Jurriaan M., Vinay Puri, Eric Segal, et al.. (2023). Concomitant cannabidiol does not impact safety and effectiveness of diazepam nasal spray for seizure clusters: Post hoc analysis of a phase 3 safety study. Epilepsy & Behavior. 144. 109248–109248. 5 indexed citations

Braun, Erica, et al.. (2023). Second-line cannabis therapy in patients with epilepsy. Clinical Neurology and Neurosurgery. 227. 107638–107638. 3 indexed citations

Flamini, Robert, Anne M. Comi, E. Martina Bebin, et al.. (2023). Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment‐resistant epilepsies in the Expanded Access Program. Epilepsia. 64(8). e156–e163. 13 indexed citations

Segal, Eric, et al.. (2022). Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study. Seizure. 98. 87–94. 9 indexed citations

Wechsler, Robert, James W. Wheless, Muhammad Zafar, et al.. (2021). PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy. Epilepsia Open. 7(2). 293–305. 18 indexed citations

Ball, Karen L., Sanjoy K. Bhattacharya, Elena Bitrian, et al.. (2021). Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations. Pediatric Neurology. 121. 59–66. 32 indexed citations

Dean, Patricia, Nancy Santilli, James W. Wheless, et al.. (2020). Low Rate of Medication Errors Supports the Ability of Patients and Caregivers to Administer NRL-1, an Intranasal Formulation of Diazepam: Interim Results from a Phase 3, Open-Label, Repeat Dose Study (1875). Neurology. 94(15_supplement). 1 indexed citations

10.

Gupta, Siddharth, et al.. (2020). Rare homozygous nonsense variant in AIMP1 causing Early Onset Epileptic Encephalopathy with Burst Suppression (EOEE-BS). European Journal of Medical Genetics. 63(9). 103970–103970. 7 indexed citations

11.

Szaflarski, Magdalena, et al.. (2020). Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Epilepsy & Behavior. 109. 107102–107102. 37 indexed citations

12.

Miller, Ian, James W. Wheless, R. Edward Hogan, et al.. (2020). Safety and Tolerability of NRL-1, an Intranasal Formulation of Diazepam, in Relationship to Usage Frequency in Subjects With Epilepsy: Interim Results From a Phase 3, Open-label, Repeat Dose Study (1992). Neurology. 94(15_supplement). 2 indexed citations

13.

Hogan, R. Edward, Daniel Tarquinio, Michael R. Sperling, et al.. (2020). Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study. Epilepsia. 61(5). 935–943. 43 indexed citations

14.

Gibbs, Sarah N., et al.. (2020). The Humanistic and Economic Burden of Pediatric Focal Seizures in the United States. Journal of Child Neurology. 35(8). 543–555. 2 indexed citations

15.

Hogan, R. Edward, et al.. (2019). Pharmacokinetic Study of Valtoco™ (NRL-1; diazepam nasal spray) in Patients with Epilepsy Under Ictal and Inter-ictal Conditions – Interim Report (P3.5-009). Neurology. 92(15_supplement). 2 indexed citations

16.

Myers, Lorna, et al.. (2019). Dissociation and other clinical phenomena in youth with psychogenic non-epileptic seizures (PNES) compared to youth with epilepsy. Seizure. 70. 49–55. 10 indexed citations

17.

Segal, Eric, et al.. (2016). Diagnostic Yield of Epilepsy Panels in Children With Medication-Refractory Epilepsy. Pediatric Neurology. 64. 66–71. 21 indexed citations

18.

Akman, Cigdem I., et al.. (2013). Generalized periodic epileptiform discharges in critically ill children: Clinical features, and outcome. Epilepsy Research. 106(3). 378–385. 16 indexed citations

19.

Segal, Eric, Martina Vendrame, Matthew Gregas, Tobias Loddenkemper, & Sanjeev V. Kothare. (2012). Effect of Treatment of Obstructive Sleep Apnea on Seizure Outcomes in Children With Epilepsy. Pediatric Neurology. 46(6). 359–362. 33 indexed citations

20.

Segal, Eric, et al.. (2007). Chorea associated with antiphospholipid antibodies in a patient with Kabuki syndrome. American Journal of Medical Genetics Part A. 143A(12). 1338–1341. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact